Thymic-renal-anal-lung dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3326OMIM:274265Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Thymic-renal-anal-lung dysplasia (TRALD), also known as FATAL syndrome (Facio-Tracheo-Anal-Lung dysplasia) or thymic-renal-anal-lung dysplasia syndrome, is an extremely rare and typically lethal congenital malformation syndrome. The condition is characterized by the combined developmental abnormalities (dysplasia) of multiple organ systems, specifically the thymus, kidneys, anus, and lungs. Affected infants present with thymic aplasia or hypoplasia leading to severe immunodeficiency, renal dysplasia or agenesis causing kidney malfunction, anal atresia (imperforate anus), and pulmonary hypoplasia or lung dysplasia resulting in severe respiratory insufficiency. Additional features that have been reported in some cases include intrauterine growth restriction, facial dysmorphism, and tracheal anomalies. The condition typically presents at birth or is detected prenatally, and affected neonates generally have a very poor prognosis, with most cases being lethal in the neonatal period due to the severity of the combined organ malformations, particularly respiratory failure from pulmonary hypoplasia. The underlying genetic cause remains incompletely understood, though familial recurrence in some cases has suggested a genetic basis. Given the extreme rarity and severity of this condition, treatment is largely supportive and palliative, with no curative therapy currently available. Management focuses on addressing individual organ system complications as they arise.

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Thymic-renal-anal-lung dysplasia.

View clinical trials →

No actively recruiting trials found for Thymic-renal-anal-lung dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Thymic-renal-anal-lung dysplasia community →

No specialists are currently listed for Thymic-renal-anal-lung dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Thymic-renal-anal-lung dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Thymic-renal-anal-lung dysplasiaForum →

No community posts yet. Be the first to share your experience with Thymic-renal-anal-lung dysplasia.

Start the conversation →

Latest news about Thymic-renal-anal-lung dysplasia

No recent news articles for Thymic-renal-anal-lung dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Thymic-renal-anal-lung dysplasia

What is Thymic-renal-anal-lung dysplasia?

Thymic-renal-anal-lung dysplasia (TRALD), also known as FATAL syndrome (Facio-Tracheo-Anal-Lung dysplasia) or thymic-renal-anal-lung dysplasia syndrome, is an extremely rare and typically lethal congenital malformation syndrome. The condition is characterized by the combined developmental abnormalities (dysplasia) of multiple organ systems, specifically the thymus, kidneys, anus, and lungs. Affected infants present with thymic aplasia or hypoplasia leading to severe immunodeficiency, renal dysplasia or agenesis causing kidney malfunction, anal atresia (imperforate anus), and pulmonary hypoplas

How is Thymic-renal-anal-lung dysplasia inherited?

Thymic-renal-anal-lung dysplasia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Thymic-renal-anal-lung dysplasia typically begin?

Typical onset of Thymic-renal-anal-lung dysplasia is neonatal. Age of onset can vary across affected individuals.